To further analyze the immune response nature of the IM classifier, we performed a TCR/BCR repertoire analysis using MiXCR based on bulk tumor RNA-seq data, finding that TCR genes (TRA and TRB), but not BCR genes, showed higher diversity in IM-positive tumors (and thus also in tumors with high TIL counts). The gene discussed is THRB; the disease is neoplasm.